The infant medicine syringes market is projected to grow from USD 651.6 million in 2026 to USD 1,071.5 million by 2036, at a CAGR of 5.1%. Oral Dosing Syringes will dominate with a 54.0% market share, while hospitals & NICUs will lead the by end user segment with a 38.0% share.